News

Keep up to date with all the latest news from LTR Medical

News2019-11-25T13:31:29+10:00

Springfusor for Aged Care Residents

August 12th, 2020|

An Aged Care group in NSW were looking for a way to deliver antibiotics and opioids to their residents, negating the need for them to attend hospitals.  NSW Sales and Education Specialist for LTR Medical Amanda Narvo, introduced them to the Springfusor.  The Springfusor is a spring-driven, portable infusion pump that can deliver medication over various time frames depending on the Flow-Control Tubing selected. Amanda conducted the initial presentation to a group of key leaders via Zoom.  The group decided to proceed with the Springfusor.  “The Springfusor provided the group the opportunity to provide care for their residents in a safe, efficient and inexpensive manner” said Amanda. Since implementation, it was discovered that a locked box was required to allow it to be used with Opioids.  Amanda jumped into action and had a prototype manufactured which met the needs of the group.  These are now being manufactured. If you have [...]

Because Plumbing Matters

August 12th, 2020|

LTR Medical is pleased to release the V-Set Clinical Report which highlights the key features of multi-line sets to deliver a risk reduction in critical medication delivery,  for use in TCI/TIVA, PCA, Paediatrics, Maternity and ICU.  The importance of reduced dead space is often forgotten, we look at current research on this, along with the importance of anti-reflux valves. For a copy of the report, fill in our contact form or call us on 1800 319 419.

Keep in touch during COVID-19

July 21st, 2020|

  During COVID-19 LTR Medical remains highly committed to providing comprehensive clinical support for our products via face to face interaction as requested or via alternative means such as Zoom, Skype or Microsoft Teams.  So please call our customer service number 1800 319 419 to get in touch.

Trade & Investment Queensland helped LTR Medical ensure continuation of parts delivery during COVID-19 lock-down in Singapore

June 2nd, 2020|

Recently Trade & Investment Queensland (TIQ) sprang into action to assist LTR Medical deliver parts necessary to provide medical devices required for an expected increased need.  A component supplier in Singapore was unable to manufacture parts required for the Springfusor and V-Set devices due to production difficulties caused by COVID-19. TIQ contacted the relevant Singapore Government department and within 3 days they had helped resolve some supply-chain issues and manufacturing was back at full capacity. LTR Medical is extremely grateful for TIQ’s assistance in making this possible. CEO Lee Rodne said it was great working with TIQ and he appreciated the support provided, resulting in front-line healthcare teams receiving the essential medical devices during the COVID-19 crisis. Read the full story here https://www.tiq.qld.gov.au/tiq-helps-ltr-keep-medical-supplies-flowing/

Springfusor 50/60ml

March 13th, 2020|

Did you know the Springfusor has a 50/60ml model? The larger volume allows delivery of a number of antibiotics. A quick check of the latest edition of The Australian Injectable Drugs Handbook (SHPA) showed around 20 antibiotics suitable for delivery in 50mls.  By reducing the volume of the diluent, you are reducing the risk of fluid overload. This is particularly relevant in patients with Renal or Cardiac co-morbidities.  Another benefit of using the Springfusor is that patients are not tethered to a large infusion pump and IV pole, allowing mobilisation, which facilitates the potential for admission avoidance and early discharge. For more information on the Springfusor 50/60ml visit our product page or call Customer Service on 1800 319 419.

Accufuser for HITH

March 9th, 2020|

With HITH services becoming a mainstay of current medical therapy, there is likely to be a rise in the use of these services due to economic pressures and patient demographics. In her 2016 article “Optimising patient safety when using elastomeric pumps to administer outpatient parenteral antibiotic therapy” Gemma Oliver found the Accufuser to be safe and easy to use. 100% of the nurses involved in the study found the Accufuser to be clinically acceptable.  The evaluation showed the Accufuser to be a safe, cost-effective strategy for OPAT treatment, well accepted by both staff and patients.  Please see the abstract here https://www.ncbi.nlm.nih.gov/pubmed/27792443. For further information on the Accufuser visit our product page or call Customer Service on  1800 319 419.

Call us Now

Call us for more information on our products on 1800 319 419.

Go to Top